Genome-wide CRISPR screens for Shiga toxins and ricin reveal Golgi proteins critical for glycosylation

Glycosylation is a fundamental modification of proteins and membrane lipids. Toxins that utilize glycans as their receptors have served as powerful tools to identify key players in glycosylation processes. Here, we carried out Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas9–mediated genome-wide loss-of-function screens using two related bacterial toxins, Shiga-like toxins (Stxs) 1 and 2, which use a specific glycolipid, globotriaosylceramide (Gb3), as receptors, and the plant toxin ricin, which recognizes a broad range of glycans. The Stxs screens identified major glycosyltransferases (GTs) and transporters involved in Gb3 biosynthesis, while the ricin screen identified GTs and transporters involved in N-linked protein glycosylation and fucosylation. The screens also identified lysosomal-associated protein transmembrane 4 alpha (LAPTM4A), a poorly characterized four-pass membrane protein, as a factor specifically required for Stxs. Mass spectrometry analysis of glycolipids and their precursors demonstrates that LAPTM4A knockout (KO) cells lack Gb3 biosynthesis. This requirement of LAPTM4A for Gb3 synthesis is not shared by its homolog lysosomal-associated protein transmembrane 4 beta (LAPTM4B), and switching the domains between them determined that the second luminal domain of LAPTM4A is required, potentially acting as a specific “activator” for the GT that synthesizes Gb3. These screens also revealed two Golgi proteins, Transmembrane protein 165 (TMEM165) and Transmembrane 9 superfamily member 2 (TM9SF2), as shared factors required for both Stxs and ricin. TMEM165 KO and TM9SF2 KO cells both showed a reduction in not only Gb3 but also other glycosphingolipids, suggesting that they are required for maintaining proper levels of glycosylation in general in the Golgi. In addition, TM9SF2 KO cells also showed defective endosomal trafficking. These studies reveal key Golgi proteins critical for regulating glycosylation and glycolipid synthesis and provide novel therapeutic targets for blocking Stxs and ricin toxicity.

[1]  John G Doench,et al.  CRISPR Screen Reveals that EHEC’s T3SS and Shiga Toxin Rely on Shared Host Factors for Infection , 2018, mBio.

[2]  LaKesla R Iles,et al.  Genome-wide siRNA screen identifies UNC50 as a regulator of Shiga toxin 2 trafficking , 2017, The Journal of cell biology.

[3]  J. Zuber,et al.  A vital sugar code for ricin toxicity , 2017, Cell Research.

[4]  Gaelen T. Hess,et al.  Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens , 2017, Nature Communications.

[5]  Y. Maeda,et al.  Genome-Wide Screening Uncovers the Significance of N-Sulfation of Heparan Sulfate as a Host Cell Factor for Chikungunya Virus Infection , 2017, Journal of Virology.

[6]  G. Matthijs,et al.  Galactose Supplementation in Patients With TMEM165-CDG Rescues the Glycosylation Defects , 2017, The Journal of clinical endocrinology and metabolism.

[7]  D. Legrand,et al.  TMEM165 deficiencies in Congenital Disorders of Glycosylation type II (CDG-II): Clues and evidences for roles of the protein in Golgi functions and ion homeostasis. , 2017, Tissue & cell.

[8]  A. Brass,et al.  Frizzled are colonic epithelial receptors for Clostridium difficile toxin B , 2016, Nature.

[9]  G. Matthijs,et al.  Glycosylation abnormalities in Gdt1p/TMEM165 deficient cells result from a defect in Golgi manganese homeostasis. , 2016, Human molecular genetics.

[10]  E. Ikonen,et al.  LAPTM4B facilitates late endosomal ceramide export to control cell death pathways. , 2015, Nature chemical biology.

[11]  J. Briggs,et al.  A structure of the COPI coat and the role of coat proteins in membrane vesicle assembly , 2015, Science.

[12]  D. Rotin,et al.  LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation , 2015, Nature Communications.

[13]  U. Schepers,et al.  Secretome Analysis Identifies Novel Signal Peptide Peptidase-Like 3 (SPPL3) Substrates and Reveals a Role of SPPL3 in Multiple Golgi Glycosylation Pathways* , 2015, Molecular & Cellular Proteomics.

[14]  Xiaojun Tan,et al.  LAPTM4B is a PtdIns(4,5)P2 effector that regulates EGFR signaling, lysosomal sorting, and degradation , 2015, The EMBO journal.

[15]  T. Yamaji,et al.  Sphingolipid Metabolism and Interorganellar Transport: Localization of Sphingolipid Enzymes and Lipid Transfer Proteins , 2015, Traffic.

[16]  R. Obst,et al.  Shedding of glycan‐modifying enzymes by signal peptide peptidase‐like 3 (SPPL3) regulates cellular N‐glycosylation , 2014, The EMBO journal.

[17]  M. Bamshad,et al.  Solving glycosylation disorders: fundamental approaches reveal complicated pathways. , 2014, American journal of human genetics.

[18]  Neville E. Sanjana,et al.  Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.

[19]  M. A. Gaston,et al.  Failure of Manganese to Protect from Shiga Toxin , 2013, PloS one.

[20]  K. Sandvig,et al.  Retrograde transport of protein toxins through the Golgi apparatus , 2013, Histochemistry and Cell Biology.

[21]  J. Carette,et al.  Deciphering the Glycosylome of Dystroglycanopathies Using Haploid Screens for Lassa Virus Entry , 2013, Science.

[22]  Michael T. McManus,et al.  A Systematic Mammalian Genetic Interaction Map Reveals Pathways Underlying Ricin Susceptibility , 2013, Cell.

[23]  H. Freeze,et al.  TMEM165 deficiency causes a congenital disorder of glycosylation. , 2012, American journal of human genetics.

[24]  A. Linstedt,et al.  Manganese Blocks Intracellular Trafficking of Shiga Toxin and Protects Against Shiga Toxicosis , 2012, Science.

[25]  D. Rotin,et al.  A Role for the Ubiquitin Ligase Nedd4 in Membrane Sorting of LAPTM4 Proteins , 2011, PloS one.

[26]  Shin Yi Chew,et al.  Genome-wide RNAi screens identify genes required for Ricin and PE intoxications. , 2011, Developmental cell.

[27]  M. Scharenberg,et al.  "Add-on" domains of Drosophila β1,4-N-acetylgalactosaminyltransferase B in the stem region and its pilot protein , 2011, Cellular and Molecular Life Sciences.

[28]  J. Schjoerring,et al.  Transmembrane nine proteins in yeast and Arabidopsis affect cellular metal contents without changing vacuolar morphology. , 2010, Physiologia plantarum.

[29]  Ron Shamir,et al.  A plasma-membrane E-MAP reveals links of the eisosome with sphingolipid metabolism and endosomal trafficking , 2010, Nature Structural &Molecular Biology.

[30]  L. Johannes,et al.  Inhibition of Retrograde Transport Protects Mice from Lethal Ricin Challenge , 2010, Cell.

[31]  W. Lencer,et al.  Cholera Toxin: An Intracellular Journey into the Cytosol by Way of the Endoplasmic Reticulum , 2010, Toxins.

[32]  L. Johannes,et al.  Shiga toxins — from cell biology to biomedical applications , 2010, Nature Reviews Microbiology.

[33]  R. Cummings,et al.  The Endoplasmic Reticulum Chaperone Cosmc Directly Promotes in Vitro Folding of T-synthase* , 2009, The Journal of Biological Chemistry.

[34]  A. Deelder,et al.  Golgi targeting of Drosophila melanogaster β4GalNAcTB requires a DHHC protein family–related protein as a pilot , 2009, The Journal of cell biology.

[35]  L. Johannes,et al.  Tracing the Retrograde Route in Protein Trafficking , 2008, Cell.

[36]  D. Grunwald,et al.  TM9SF4 is required for Drosophila cellular immunity via cell adhesion and phagocytosis , 2008, Journal of Cell Science.

[37]  Brandi L. Cantarel,et al.  The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics , 2008, Nucleic Acids Res..

[38]  R. Cummings,et al.  Regulation of protein O-glycosylation by the endoplasmic reticulum–localized molecular chaperone Cosmc , 2008, The Journal of cell biology.

[39]  B. Ramakrishnan,et al.  Letter to the Glyco-Forum: catalytic domains of glycosyltransferases with 'add-on' domains. , 2007, Glycobiology.

[40]  J. Osterloh,et al.  Ricin poisoning: a comprehensive review. , 2005, JAMA.

[41]  K. Sandhoff,et al.  Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. , 2005, Annual review of cell and developmental biology.

[42]  P. Tarr,et al.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome , 2005, The Lancet.

[43]  P. Stanley,et al.  Suppressors of alpha(1,3)fucosylation identified by expression cloning in the LEC11B gain-of-function CHO mutant. , 2004, Glycobiology.

[44]  R. Cummings,et al.  A unique molecular chaperone Cosmc required for activity of the mammalian core 1 β3-galactosyltransferase , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[45]  V. Ling,et al.  Lysosome-associated protein transmembrane 4 alpha (LAPTM4 alpha) requires two tandemly arranged tyrosine-based signals for sorting to lysosomes. , 2002, The Biochemical journal.

[46]  B. Ramakrishnan,et al.  alpha-Lactalbumin (LA) stimulates milk beta-1,4-galactosyltransferase I (beta 4Gal-T1) to transfer glucose from UDP-glucose to N-acetylglucosamine. Crystal structure of beta 4Gal-T1 x LA complex with UDP-Glc. , 2001, The Journal of biological chemistry.

[47]  M. Watarai,et al.  Phylogenetic diversity and similarity of active sites of Shiga toxin (Stx) in Shiga toxin-producing Escherichia coli (STEC) isolates from humans and animals , 2001, Epidemiology and Infection.

[48]  P. Cosson,et al.  Phg1p Is a Nine-transmembrane Protein Superfamily Member Involved in Dictyostelium Adhesion and Phagocytosis* , 2000, The Journal of Biological Chemistry.

[49]  R. Cummings,et al.  Cloning of Gb3 Synthase, the Key Enzyme in Globo-series Glycosphingolipid Synthesis, Predicts a Family of α1,4-Glycosyltransferases Conserved in Plants, Insects, and Mammals* , 2000, The Journal of Biological Chemistry.

[50]  Kazuro Furukawa,et al.  Molecular Cloning of Globotriaosylceramide/CD77 Synthase, a Glycosyltransferase That Initiates the Synthesis of Globo Series Glycosphingolipids* , 2000, The Journal of Biological Chemistry.

[51]  C. Cass,et al.  Mouse transporter protein, a membrane protein that regulates cellular multidrug resistance, is localized to lysosomes. , 1999, Cancer research.

[52]  V. Ling,et al.  A Mammalian Lysosomal Membrane Protein Confers Multidrug Resistance upon Expression in Saccharomyces cerevisiae * , 1999, The Journal of Biological Chemistry.

[53]  R. Pepperkok,et al.  The KDEL retrieval system is exploited by Pseudomonas exotoxin A, but not by Shiga-like toxin-1, during retrograde transport from the Golgi complex to the endoplasmic reticulum. , 1999, Journal of cell science.

[54]  S. Pfeffer,et al.  Characterization of a 76 kDa endosomal, multispanning membrane protein that is highly conserved throughout evolution. , 1998, Gene.

[55]  R J Read,et al.  Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. , 1998, Biochemistry.

[56]  C. Cass,et al.  Identification of a Novel Membrane Transporter Associated with Intracellular Membranes by Phenotypic Complementation in the Yeast Saccharomyces cerevisiae(*) , 1996, The Journal of Biological Chemistry.

[57]  R. Collier,et al.  Protective antigen‐binding domain of anthrax lethal factor mediates translocation of a heterologous protein fused to its amino‐ or carboxy‐terminus , 1995, Molecular microbiology.

[58]  P. Stanley,et al.  Activation of two new alpha(1,3)fucosyltransferase activities in Chinese hamster ovary cells by 5-azacytidine. , 1991, Cell regulation.

[59]  D. Fiete,et al.  Structural determinants of Ricinus communis agglutinin and toxin specificity for oligosaccharides. , 1979, The Journal of biological chemistry.

[60]  K. Sandvig,et al.  Shiga toxins. , 2012, Toxicon : official journal of the International Society on Toxinology.

[61]  P. Stanley Golgi glycosylation. , 2011, Cold Spring Harbor Perspectives in Biology.

[62]  C. Lingwood Verotoxins and their glycolipid receptors. , 1993, Advances in lipid research.

[63]  Lingwood Ca Verotoxins and their glycolipid receptors. , 1993 .